CoChat
Sign Up
Cited by 105Down syndrome and intellectual disability researchAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Cerebrovascular pathology in Down syndrome and Alzheimer disease

Open access
Head, Elizabeth, Phelan, Michael J., Doran, Eric, Kim, Ronald C., Poon, Wayne W., Schmitt, Frederick A., Lott, Ira T.·2017·Acta Neuropathologica Communications
DOI 10.1186/s40478-017-0499-4PMC PMC5709935
Open this paper in CoChat — free accountOpen PDF

Abstract

People with Down syndrome (DS) are at high risk for developing Alzheimer disease (AD) with age. Typically, by age 40 years, most people with DS have sufficient neuropathology for an AD diagnosis. Interestingly, atherosclerosis and hypertension are atypical in DS with age, suggesting the lack of these vascular risk factors may be associated with reduced cerebrovascular pathology. However, because the extra copy of APP leads to increased beta-amyloid peptide (Aβ) accumulation in DS, we hypothesized that there would be more extensive and widespread cerebral amyloid angiopathy (CAA) with age in DS relative to sporadic AD. To test this hypothesis CAA, atherosclerosis and arteriolosclerosis were used as measures of cerebrovascular pathology and compared in post mortem tissue from individuals with DS (n = 32), sporadic AD (n = 80) and controls (n = 37). CAA was observed with significantly higher frequencies in brains of individuals with DS compared to sporadic AD and controls. Atherosclerosis and arteriolosclerosis were rare in the cases with DS. CAA in DS may be a target for future interventional clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40478-017-0499-4

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Percentage of autopsy cases by severity of cerebrovascular outcome and cohort. Percentages for Atherosclerosis, Arteriolosclerosis, and Cerebral Amyloid Angiopathy (CAA) add to 100% within each cohort, separately. More moderate and severe CAA findings were associated particularly with the DS cohort
Fig. 1 Percentage of autopsy cases by severity of cerebrovascular outcome and cohort. Percentages for Atherosclerosis, Arteriolosclerosis, and Cerebral Amyloid Angiopathy (CAA) add to 100% within each cohort, separately. More moderate and severe CAA findings were associated particularly with the DS cohortCC BY · PubMed Central
Fig. 2 Age at autopsy across the three cohorts (DS, AD, Ctrl) showing that the DS cases were younger than the AD and Control (Ctrl) cases. Individual data points are shown in open circles, group means in solid, red circles. Error bars show plus-and-minus one standard deviation from the mean
Fig. 2 Age at autopsy across the three cohorts (DS, AD, Ctrl) showing that the DS cases were younger than the AD and Control (Ctrl) cases. Individual data points are shown in open circles, group means in solid, red circles. Error bars show plus-and-minus one standard deviation from the meanCC BY · PubMed Central
Fig. 3 Arteriolosclerosis as a function of age in DS, AD and Controls. Individual data points shown as open circles, group means as filled circles. Error bars show plus-and-minus one standard deviation from the mean
Fig. 3 Arteriolosclerosis as a function of age in DS, AD and Controls. Individual data points shown as open circles, group means as filled circles. Error bars show plus-and-minus one standard deviation from the meanCC BY · PubMed Central
Fig. 4 Atherosclerosis as a function of age in DS, AD and Controls. Individual data points shown as open circles, group means as filled circles. Error bars show plus-and-minus one standard deviation from the mean
Fig. 4 Atherosclerosis as a function of age in DS, AD and Controls. Individual data points shown as open circles, group means as filled circles. Error bars show plus-and-minus one standard deviation from the meanCC BY · PubMed Central
Fig. 5 Probability of CAA severity as a function of age-at-autopsy in DS cohort. Error bars show the upper and lower limits of the 95% confidence interval. The number of DS cases with no or mild CAA decreases with age. The number of people with DS with moderate CAA remains relatively stable but the numbers of cases with severe CAA increases with age
Fig. 5 Probability of CAA severity as a function of age-at-autopsy in DS cohort. Error bars show the upper and lower limits of the 95% confidence interval. The number of DS cases with no or mild CAA decreases with age. The number of people with DS with moderate CAA remains relatively stable but the numbers of cases with severe CAA increases with ageCC BY · PubMed Central
Fig. 6 Probability curves for CAA severity based on age-at-autopsy in DS cohort. The age at which CAA shifts from mild, to moderate to severe are estimated based on age. Moderate to severe findings were more likely at upper ages
Fig. 6 Probability curves for CAA severity based on age-at-autopsy in DS cohort. The age at which CAA shifts from mild, to moderate to severe are estimated based on age. Moderate to severe findings were more likely at upper agesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Research works printed but not linked: 1

  1. R_Core_Team (2016) A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna

Cited by

Sorted by citations

Items 101–105 of 105

Related

See all

Metadata

Authors
Head, E., Phelan, M. J., Doran, E., Kim, R. C., Poon, W. W., Schmitt, F. A., & Lott, I. T.
Affiliations
  • University of Kentucky (US)
  • University of California, Irvine (US)
Corresponding author
Head, Elizabeth
ORCID
Venue
Acta Neuropathologica Communications
Publisher
Springer Science and Business Media LLC
Published
2017-12
Volume
5
Issue
1
Pages
93-93
ISSN
2051-5960 (ISSN-L)
DOI
10.1186/s40478-017-0499-4
PMC
PMC5709935
OpenAlex
W2771929031
Cited by
105
References
61
Citations by year
2026: 9 · 2025: 22 · 2024: 18 · 2023: 9 · 2022: 12 · 2021: 15 · 2020: 8 · 2019: 8 · 2018: 4
FWCI
5.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Acta Neuropathologica Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • UKnowledge (University of Kentucky) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institute on Aging (P50AG16573, R01AG21912)
  • National Institute of Child Health and Human Development (R01HD065160, R01HD064993)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Down syndrome, Alzheimer's disease, cerebral amyloid angiopathy, cerebrovascular pathology, atherosclerosis, arteriolosclerosis, amyloid-beta deposition, vascular risk factors, postmortem brain
MeSH terms
Age Factors, Aged, Aged, 80 and over, Alzheimer Disease, Down Syndrome, Female, Humans, Male, Middle Aged, Probability, Cohort Studies, Cerebral Amyloid Angiopathy, Atherosclerosis, Arteriolosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review